EUVIMEDEUVIMED entdecken
Crossref

Intravenous diltiazem infusions for rapid atrial fibrillation or flutter in the emergency department: A retrospective, exploratory analysis

Tony Zitek iD, Kristina Pagano iD, Carolina Fernandez, Sarah Zajd, Murtaza Akhter iD, Tarang Kheradia, Georgeta Vaidean, David A Farcy

Academic Emergency Medicine · 2024

DOI: 10.1111/acem.14989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academic Emergency Medicine, 2024. Verfasst von Tony Zitek und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Mount Sinai Medical Center, Miami Beach, Florida, USA. Hauptthemen laut MEDLINE: Diltiazem, Atrial Fibrillation, Emergency Service, Hospital, Atrial Flutter. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Emergency physicians commonly treat patients with atrial fibrillation (AF) or atrial flutter (AFL) with rapid ventricular response, and intravenous (IV) diltiazem is the most commonly used medication for rate control of such patients. We sought to compare rate control success and safety outcomes for emergency department (ED) patients with AF or AFL who, after a diltiazem bolus, received a diltiazem drip compared to those who did not receive a drip.

Methods

We performed a retrospective cohort study comparing outcomes of ED patients from a single hospital system with AF and AFL and a heart rate (HR) > 100 beats/min who received a diltiazem drip after an IV diltiazem bolus to those who received no drip. The primary outcome was a HR < 100 beats/min at the time of ED disposition. Secondary outcomes were hospital length of stay and safety (hypotension, electrical cardioversion, vasopressor use, and death). We compared groups using propensity score matching.

Results

Between January 1, 2020, and November 8, 2022, there were 746 AF or AFL patients eligible for analysis. Of those, 382 (51.2%) received a diltiazem drip and 364 (48.8%) did not. In the unadjusted analysis, the last recorded ED HR was

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiltiazemAtrial FibrillationEmergency Service, HospitalAtrial FlutterHumansRetrospective StudiesMaleFemaleAgedMiddle AgedInfusions, IntravenousLength of StayAnti-Arrhythmia AgentsCalcium Channel BlockersPropensity Score

Substanzen

DiltiazemAnti-Arrhythmia AgentsCalcium Channel Blockers

Autor:innen und Institutionen

  • Department of Emergency Medicine, Mount Sinai Medical Center, Miami Beach, Florida, USA.
  • Herbert Wertheim College of Medicine at Florida International University, Miami, Florida, USA.
  • Department of Emergency Medicine, Penn State School of Medicine, State College, Pennsylvania, USA.
  • Hershey Medical Center, State College, Pennsylvania, USA.

ORCID-Profile: Tony Zitek, Kristina Pagano, Murtaza Akhter

Zitieren

APA

Zitek, T., Pagano, K., Fernandez, C., Zajd, S., Akhter, M., Kheradia, T., Vaidean, G., & Farcy, D. A. (2024). Intravenous diltiazem infusions for rapid atrial fibrillation or flutter in the emergency department: A retrospective, exploratory analysis. Academic Emergency Medicine. https://doi.org/10.1111/acem.14989

Vancouver

Zitek T, Pagano K, Fernandez C, Zajd S, Akhter M, Kheradia T, et al. Intravenous diltiazem infusions for rapid atrial fibrillation or flutter in the emergency department: A retrospective, exploratory analysis. Academic Emergency Medicine. 2024. doi:10.1111/acem.14989

BibTeX
@article{Zitek2024,
  author = {Zitek, Tony and Pagano, Kristina and Fernandez, Carolina and Zajd, Sarah and Akhter, Murtaza and Kheradia, Tarang and Vaidean, Georgeta and Farcy, David A},
  title = {Intravenous diltiazem infusions for rapid atrial fibrillation or flutter in the emergency department: A retrospective, exploratory analysis},
  journal = {Academic Emergency Medicine},
  year = {2024},
  doi = {10.1111/acem.14989}
}
Kostenlos starten →